Buscar resultados de ensayos clínicos
ACTH-Secreting Pituitary Adenoma - 38 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Rhinological Outcomes in Endonasal Pituitary Surgery Condición:
|
Recruiting |
Nombre del estudio: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Condición:
|
Recruiting |
Nombre del estudio: Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors Condición:
Fecha: 2016-04-20 Intervenciones: Drug: Pasireotide LAR Pasireotide LAR (SIGNIFOR® LAR) |
Terminated |
Nombre del estudio: Pasireotide Therapy in Patients With Nelson's Syndrome Condición: Nelson Syndrome Fecha: 2012-06-08 Intervenciones: Drug: Pasireotide 4 Weeks pasireotide 0.6mg s/c injections twice daily followed by 24 weeks treatment wi |
Terminated |
Nombre del estudio: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin Condición:
Intervenciones: Drug: pasireotide LAR Investigational drug pasireotide LAR was supplied in vials with 20 mg or 40 mg pow |
Completed |
Nombre del estudio: An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome Condición: Cushing's Syndrome Fecha: 2009-07-09 Intervenciones: Drug: mifepristone Mifepristone 300 mg to 1200 mg once daily |
Completed |
Nombre del estudio: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome Condición: Cushing's Syndrome Fecha: 2007-12-05 Intervenciones: Drug: mifepristone Patients take mifepristone by mouth once a day. The dose is increased during schedule |
Recruiting |
Nombre del estudio: Study to Evaluate CORT125134 in Patients With Cushing's Syndrome Condición: Cushing's Syndrome Fecha: 2016-06-15 Intervenciones: Drug: CORT125134 |